,2021-09-25,2021-06-26,2021-03-27,2020-12-26
Research Development,214057000.0,200981000.0,203214000.0,199672000.0
Effect Of Accounting Charges,,,,
Income Before Tax,275386000.0,372059000.0,250514000.0,391466000.0
Minority Interest,,,,
Net Income,259039000.0,316997000.0,220029000.0,333548000.0
Selling General Administrative,199220000.0,208698000.0,188683000.0,220045000.0
Gross Profit,695947000.0,780851000.0,641556000.0,790984000.0
Ebit,282670000.0,371172000.0,249659000.0,371267000.0
Operating Income,282670000.0,371172000.0,249659000.0,371267000.0
Other Operating Expenses,,,,
Interest Expense,,,,
Extraordinary Items,,,,
Non Recurring,,,,
Other Items,,,,
Income Tax Expense,16347000.0,55062000.0,30485000.0,57918000.0
Total Revenue,1191973000.0,1326905000.0,1072327000.0,1351405000.0
Total Operating Expenses,909303000.0,955733000.0,822668000.0,980138000.0
Cost Of Revenue,496026000.0,546054000.0,430771000.0,560421000.0
Total Other Income Expense Net,-7284000.0,887000.0,855000.0,20199000.0
Discontinued Operations,,,,
Net Income From Continuing Ops,259039000.0,316997000.0,220029000.0,333548000.0
Net Income Applicable To Common Shares,259039000.0,316997000.0,220029000.0,333548000.0
